Save your place

Sign in to WhoBought

Please try again later.

Jim Simons's Arbutus Biopharma Corporation (ABUS) position

Not anymore: Jim Simons fully exited ABUS in Q3 2023. The position peaked at an amount we cannot price in Q1 2021.
View full portfolio →
Value at exit
an amount we cannot price
Shares at exit
321K
Quarter-end price
No quarter-end price available

Average buy price is hidden here because at least one covered purchase quarter has no usable local mean price.

ABUS price vs Simons's position

Dates
$4.4$4.6$4.8← Earlier —3 purchases, 1 sell
Average closing price · filing quarter
Price range · filing quarter

Every quarterly change

Quarter Action Shares change Est. value change Δ Own Shares held Filing date
Q3 2023 Exited −321K −100.0% 0 Nov 14, 2023
Q2 2023 Added +46K +16.8% 321K Aug 11, 2023
Q1 2023 Added +240K +682.6% 275K May 12, 2023
Q4 2022 Reduced −11K −23.0% 35K Feb 13, 2023
Q3 2022 New +46K 46K Nov 14, 2022
Q1 2021 First covered 1.0M May 13, 2021
Data through Q3 2023 · filed Nov 14, 2023
6 grouped rows from 6 quarters

More Simons positions

Common questions

Does Jim Simons own ABUS?

Not currently. Jim Simons fully exited ABUS in Q3 2023, and the complete history is above. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

When did Jim Simons buy ABUS?

Jim Simons held ABUS since at least Q1 2021, when this filing coverage begins; the opening snapshot is not a disclosed purchase. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

Did Jim Simons sell ABUS?

Yes. Jim Simons reduced and then fully exited ABUS by Q3 2023; the reductions are in the table above. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

How many shares of ABUS does Jim Simons own?

None as of the latest filing: Jim Simons has exited ABUS. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

What price did Jim Simons pay for ABUS?

Jim Simons began building the ABUS position before our 13F history starts, so an exact average buy price cannot be estimated without understating it. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

How are the estimated trade prices calculated?

13F filings disclose quarter-end holdings, not trade dates or execution prices. These estimates use each covered quarter's average market price; the add average excludes the opening position and quarters without price data. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.